MEDI:GATE NEWS Daewoong Pharmaceutical’s partner, begins global phase 2 clinical trial for botulinum toxin migraine treatment
Olipass “Non-narcotic analgesic drug phase 2 clinical trial as scheduled in the second half of the year”
Olipass, a non-narcotic analgesic drug in Australia clinical trial phase 1b has a peculiarity…”A thorough analysis of the cause”
MEDI:GATE NEWS Green Cross Well-being Lineeju, Corona 19 treatment clinical plan approved by the Ministry of Food and Drug Safety